Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Curanex Pharmaceuticals Inc Common Stock
No Price
01.05.2026 21:00
Current Prices from Curanex Pharmaceuticals Inc Common Stock
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
CURX
USD
01.05.2026 21:00
0,38 USD
-0,04 USD
-8,90 %
IEX
CURX
USD
01.05.2026 19:19
0,37 USD
-0,05 USD
-11,20 %
Share Float & Liquidity
Free Float26,59 %
Shares Float7,53 M
Shares Outstanding28,34 M
Company Profile for Curanex Pharmaceuticals Inc Common Stock Share
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. The company was founded in 1996 and is headquartered in Jericho, New York.
